T 2223/10 (Antibody binding GM1 ganglioside-bound amyloid beta-protein/MEDICAL & BIOLOGICAL LABORATORIES) of 19.03.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T222310.20150319
- Date of decision
- 19 March 2015
- Case number
- T 2223/10
- Petition for review of
- -
- Application number
- 02755765.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Antibody recognizing GM1 ganglioside-bound amyloid beta-protein and DNA encoding the antibody
- Applicant name
- Medical & Biological Laboratories Co., Ltd.
Japan as represented by The Director of Chubu
National Hospital
Yanagisawa, Katsuhiko - Opponent name
- Glaxo Group Limited
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83European Patent Convention R 99(2)Rules of procedure of the Boards of Appeal Art 12(1)Rules of procedure of the Boards of Appeal Art 12(4)
- Keywords
- Admissibility of appeal - (yes)
Late-filed evidence - admitted (yes)
Novelty - (yes)
Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- T 0015/01
Order
For these reasons it is decided that:
The appeal is dismissed.